Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 172
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02177838 | Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer | ||
| NCT05296421 | Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer | ||
| NCT00295932 | Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma | ||
| NCT00726596 | Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer | ||
| NCT01745588 | Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma | ||
| NCT01220973 | Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer | ||
| NCT00176605 | Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer | ||
| NCT01515085 | MRI-Guided Laser Induced Thermal Therapy | ||
| NCT00895115 | Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer | ||
| NCT02420652 | Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy | ||
| NCT04829383 | A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma | ||
| NCT00962845 | Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | ||
| NCT03228147 | Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment | ||
| NCT01407562 | Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors | ||
| NCT00176631 | Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | ||
| NCT03112668 | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | ||
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | ||
| NCT01828476 | Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer | ||
| NCT01694589 | A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer | ||
| NCT00939380 | Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial | ||
| NCT05483491 | KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer | ||
| NCT00667901 | Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | ||
| NCT02400190 | The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) | ||
| NCT02203578 | Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease | ||
| NCT00176540 | Dextromethorphan in Treating Patients With Fatigue Caused by Cancer | ||
| NCT03233555 | Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer | ||
| NCT00323063 | Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer | ||
| NCT00496600 | Phase I Study of Patupilone and RAD001 | ||
| NCT00899808 | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer | ||
| NCT01510119 | Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma | ||
| NCT03028948 | Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma | ||
| NCT07681791 | Sun Safe Together: A Digital Skin Cancer Prevention Intervention for Adolescents and Their Parents | ||
| NCT02144675 | Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia | ||
| NCT02688192 | Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors | ||
| NCT07210567 | Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors | ||
| NCT00878657 | Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer | ||
| NCT04141449 | A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation | ||
| NCT00118066 | Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia | ||
| NCT04163952 | Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin | ||
| NCT02117817 | Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer | ||
| NCT00582829 | Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients | ||
| NCT00161213 | Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer | ||
| NCT04285268 | Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma | ||
| NCT02105116 | AML Therapy With Irradiated Allogeneic Cells | ||
| NCT00765765 | Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer | ||
| NCT00251186 | First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients | ||
| NCT00003365 | Sulindac and Plant Compounds in Preventing Colon Cancer | ||
| NCT00161187 | Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor | ||
| NCT00608972 | Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer | ||
| NCT05785780 | Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings |
